Biotech Startups
9,920 companies tagged Biotech, with their investors and founders.
LUCA Science develops mitochondrial therapies that supply functional, storable mitochondria to damaged or dysfunctional cells and tissues to restore cellular energy production, targeting conditions such as ischemia-reperfusion injuries including cerebral and myocardial infarction. The company works in the biopharmaceutical field, building a platform based on its proprietary iMIT mitochondria technology.
2 investors
Lucerna Dynamics provides software that identifies injection errors in nuclear medicine procedures, evaluates their impact, and helps reduce error frequency for healthcare teams.
2 investors
Lucid Scientific develops Resipher, a technology for live, continuous, and noninvasive monitoring of cellular oxygen consumption rate to study cell metabolism. It serves researchers and scientists in cell biology and cell culture labs.
2 investors
Lumicell develops a fluorescence-guided intraoperative imaging technology, including its LUMISIGHT optical imaging agent, that illuminates cancerous tissue in the surgical cavity to help surgeons remove residual cancer during procedures such as lumpectomy. The platform is aimed at surgical oncology, starting with breast cancer, and its flagship product has received FDA approval.
2 investors
LUMICKS develops life science research tools that measure and apply forces around biological interactions to link structural and 'omics analysis to functional outcomes at the molecular and cellular level. Its instruments serve academic research, drug development, bioprocessing, and immuno-oncology markets.
2 investors
LuminUltra provides microbial monitoring and testing solutions, including ATP field testing (Bugcount), qPCR diagnostics (Genecount), lab services, and a digital platform (Relay), to help industries detect and manage microbial risks. The company serves sectors such as food and beverage and water systems through products, research, and lab services.
2 investors
LumiThera develops the Valeda Light Delivery System, an FDA-authorized photobiomodulation (PBM) device that applies multiple light wavelengths to treat early and intermediate dry age-related macular degeneration (AMD). The non-invasive treatment is intended for eyecare practitioners to help patients maintain or improve visual acuity.
2 investors
Luyef develops precision fermentation and cell-based technologies to produce animal-derived products for food, biomedicine, and cosmetics without factory farming or environmental impact. The company targets industries seeking sustainable, ethical, and cost-effective alternatives to conventional animal-based materials.
2 investors
LymeAlert makes a lab-quality, at-home test that detects Lyme disease pathogens in the tick itself rather than the person or pet, returning results in under 30 minutes with app-based guidance on next steps. Developed at MIT, it is aimed at families, pets, and animals at risk of tick-borne illness.
2 investors
Lyric Bio develops tissue-engineered bioreactors that use a proprietary laser-printed cellular substrate to grow high-density human cells and produce human immunoglobulin (IvIg, ScIg) from a single donor. The company aims to reduce Ig therapy's dependence on blood and plasma donations and enable scalable manufacturing of complex donor-derived biologics.
2 investors
Madrigal Pharmaceuticals is a biopharmaceutical company developing treatments for metabolic-associated steatohepatitis (MASH). The company focuses on improving care for patients with this liver disease through innovative drug development and collaboration.
2 investors
Magic Valley is an Australian cultivated meat company using iPSC technology to produce real meat without animal farming. The company targets consumers and the broader food industry seeking sustainable meat alternatives.
2 investors
Magnet Biomedicine develops TrueGlueβ’, a molecular glue discovery platform for designing small molecule therapeutics that induce novel protein-protein interactions to treat cancer and immune disorders. The platform systematically identifies molecular glues capable of targeting historically difficult-to-drug proteins in precision medicine.
2 investors
Powerhouse.bio is a biotechnology company that combines experimental biology with applied machine learning. The company works at the intersection of biology and computational science.
2 investors
Manifest Technologies develops the NAIO computational neuroimaging platform, which uses AI to integrate and analyze multi-modal neuroimaging data for biomarker discovery, target validation, and patient selection. It serves pharmaceutical CNS R&D and healthcare providers to support diagnosis and treatment of central nervous system disorders.
2 investors
Marker Therapeutics develops novel T cell therapies, including adoptive T cell therapy approaches, for clinical applications in oncology and other diseases with high unmet need. The company focuses on advancing cell therapy candidates from research through clinical development.
2 investors
Mass Dynamics builds software systems for research teams to interpret complex biological data and make data-driven decisions. The company combines scientific rigor with user-focused product design by integrating scientists, engineers, and product builders in collaborative development.
2 investors
Matrisome Bio is an oncology biotech developing therapies based on extracellular matrix (ECM) biology, using a protein engineering platform to target the tumor microenvironment. Its work spans multiple modalities including radioligand therapies.
2 investors
MattiQ accelerates materials science discovery using a platform for computational experimentation and design across energy, computing, transportation, and space industries.
2 investors
Maxwell Biomedical develops a device-based alternative to catheter ablation for atrial fibrillation, using closed-loop adaptive left atrial multisite pacing and Spatial Resynchronization Therapy (SRT) to terminate AF without high-energy shock. Its work centers on wirelessly powered leadless pacemakers and cardiac resynchronization technology for cardiac rhythm disorders.
2 investors
MBD (μ£Όμνμ¬ μ λΉλ) is a biotechnology company that describes itself as technology-driven and posts updates on its research and expanding disease indications.
2 investors
mDETECT develops methylation- and NGS-based liquid biopsy tests to monitor metastatic cancer, aimed at clinical validation and commercial diagnostic use. The company's work centers on tracking disease in patients battling metastatic cancer.
2 investors
MDxHealth is a commercial-stage precision diagnostics company offering molecular diagnostic tests to guide the diagnosis and treatment of prostate cancer and other urologic diseases. Its tests use proprietary genetic, epigenetic, and molecular technologies and serve physicians, patients, payers, and providers.
2 investors
Medium Bio engineers customized proteins using AI and protein design to create affinity reagents for research teams and diagnostic developers. The company accelerates molecular tool development from design to experimental validation within weeks.
2 investors